CellWell record HH-172411
Treatment-Refractory Hypothyroidism due to Proteinuria During Combined Immune Checkpoint and Tyrosine Kinase Inhibitor Therapy - A Case Report
Jessica K Williams; Anne K Brinkman; Amori Y Salami-Henry; Nupur J Kikani; Steven P Weitzman
2026
In plain language
Proteinuria from kinase inhibitor therapy increased urinary protein-bound thyroid hormone loss, requiring doubled levothyroxine dosing to normalize TSH.
- Evidence
- Emerging
- Design
- Case report
Cite this record: https://thecellwell.org/studies/HH-172411
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.